PETER LIM, M.D.
Specialist · RENO, NV
Individual Active NPI 1407891534
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 894 | 74,102 | $6,699,248 | $2,084,751 | $1,656,987 |
| 2023 | 546 | 50,957 | $3,879,316 | $1,385,587 | $1,095,444 |
| 2022 | 523 | 74,481 | $3,845,180 | $1,301,559 | $1,025,092 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9267 | Injection, paclitaxel, 1 mg | 39,041 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 7,000 | $42 | $33 |
| J9035 | Injection, bevacizumab, 10 mg | 5,820 | $72 | $58 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,972 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,988 | $0 | $0 |
| J9045 | Injection, carboplatin, 50 mg | 1,372 | $3 | $3 |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 1,068 | $138 | $109 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 718 | $89 | $64 |
| 96375 | Injection of additional new drug or substance into vein | 606 | $15 | $12 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 376 | $178 | $138 |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 360 | $134 | $107 |
| J3490 | Unclassified drugs | 300 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Specialist | 174400000X | ✓ | 8759 | NV |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Specialist providers in Nevada
- NPI 1972700482
- NPI 1689605545
- NPI 1902963143
- NPI 1639599079
- NPI 1841245792
- NPI 1396826632
- NPI 1710111919
- NPI 1861606089
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.